Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q1 2021 · 10-Q
Revenue$16.35M$16.35M+133.6% vs Q1 2020 Net Income-$18.69M-$18.69MN/M vs Q1 2020 EPS Diluted-$0.33-$0.33N/M vs Q1 2020 Operating Income-$18,742,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
Free Cash Flowderived$66,947,000N/M Margins · derivedOperating margin-114.6%+278.3 pt vs Q1 2020
Net margin-114.3%+269.2 pt vs Q1 2020
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end